TAp63gamma is required for the late stages of myogenesis

References

• Weintraub H. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 1993; 75(7):1241-4; PMID:8269506; http://dx.doi.org/10.1016/0092-8674(93)90610-3
   PubMed Web of Science ®Google Scholar
• Blackwell TK, Weintraub H. Differences and similarities in DNA-binding preferences of MyoD and E2A protein complexes revealed by binding site selection. Science 1990; 250(4984):1104-10; PMID:2174572; http://dx.doi.org/10.1126/science.2174572
   PubMed Web of Science ®Google Scholar
• Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005; 132(12):2685-95; PMID:15930108; http://dx.doi.org/10.1242/dev.01874
   PubMed Web of Science ®Google Scholar
• Braun T, Gautel M. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 2011; 12(6):349-61; PMID:21602905; http://dx.doi.org/10.1038/nrm3118
   PubMed Web of Science ®Google Scholar
• Di Palma T, Filippone MG, Pierantoni GM, Fusco A, Soddu S, Zannini M. Pax8 has a critical role in epithelial cell survival and proliferation. Cell Death Dis 2013; 4:e729; PMID:23868062; http://dx.doi.org/10.1038/cddis.2013.262
   PubMed Web of Science ®Google Scholar
• Simonatto M, Marullo F, Chiacchiera F, Musaró A, Wang JY, Latella L, Puri PL. DNA damage-activated ABL-MyoD signaling contributes to DNA repair in skeletal myoblasts. Cell Death Differ 2013; 20(12):1664-74; PMID:24056763; http://dx.doi.org/10.1038/cdd.2013.118
   PubMed Web of Science ®Google Scholar
• Gozo MC, Aspuria PJ, Cheon DJ, Walts AE, Berel D, Miura N, Karlan BY, Orsulic S. Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis. Cell Death Differ 2013; 20(8):1031-42; PMID:23645207; http://dx.doi.org/10.1038/cdd.2013.34
   PubMed Web of Science ®Google Scholar
• Fortini P, Ferretti C, Pascucci B, Narciso L, Pajalunga D, Puggioni EM, Castino R, Isidoro C, Crescenzi M, Dogliotti E. DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity. Cell Death Differ 2012; 19(11):1741-9; PMID:22705848; http://dx.doi.org/10.1038/cdd.2012.53
   PubMed Web of Science ®Google Scholar
• Luo W, Wu H, Ye Y, Li Z, Hao S, Kong L, Zheng X, Lin S, Nie Q, Zhang X. The transient expression of miR-203 and its inhibiting effects on skeletal muscle cell proliferation and differentiation. Cell Death Dis 2014; 5:e1347; PMID:25032870; http://dx.doi.org/10.1038/cddis.2014.289
   PubMed Web of Science ®Google Scholar
• Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, Zhao SH. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell Death Dis 2013; 4:e934; PMID:24287695; http://dx.doi.org/10.1038/cddis.2013.462
   PubMed Web of Science ®Google Scholar
• Amelio I, Lena AM, Viticchiè G, Shalom-Feuerstein R, Terrinoni A, Dinsdale D, Russo G, Fortunato C, Bonanno E, Spagnoli LG, et al. miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol 2012; 199(2):347-63; PMID:23071155; http://dx.doi.org/10.1083/jcb.201203134
   PubMed Web of Science ®Google Scholar
• Forterre A, Jalabert A, Chikh K, Pesenti S, Euthine V, Granjon A, Errazuriz E, Lefai E, Vidal H, Rome S. Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts during muscle cell differentiation. Cell Cycle 2014 Jan 1; 13(1):78-89; http://dx.doi.org/10.4161/cc.26808
   PubMed Web of Science ®Google Scholar
• Alexander MS, Kawahara G, Motohashi N, Casar JC, Eisenberg I, Myers JA, Gasperini MJ, Estrella EA, Kho AT, Mitsuhashi S, et al. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death Differ 2013; 20(9):1194-208; PMID:23764775; http://dx.doi.org/10.1038/cdd.2013.62
   PubMed Web of Science ®Google Scholar
• Wei W, He HB, Zhang WY, Zhang HX, Bai JB, Liu HZ, Cao JH, Chang KC, Li XY, Zhao SH. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 2013; 4:e668; PMID:23764849; http://dx.doi.org/10.1038/cddis.2013.184
   PubMed Web of Science ®Google Scholar
• Puri PL, Sartorelli V. Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol 2000; 185(2):155-73; PMID:11025438; http://dx.doi.org/10.1002/1097-4652(200011)185:2%3c155::AID-JCP1%3e3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Novitch BG, Mulligan GJ, Jacks T, Lassar AB. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J Cell Biol 1996; 135(2):441-56; PMID:8896600; http://dx.doi.org/10.1083/jcb.135.2.441
   PubMed Web of Science ®Google Scholar
• Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 1996; 10(23):3051-64; PMID:8957005; http://dx.doi.org/10.1101/gad.10.23.3051
   PubMed Web of Science ®Google Scholar
• Cam H, Griesmann H, Beitzinger M, Hofmann L, Beinoraviciute-Kellner R, Sauer M, Hüttinger-Kirchhof N, Oswald C, Friedl P, Gattenlöhner S, et al. p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 2006; 10(4):281-93; PMID:17045206; http://dx.doi.org/10.1016/j.ccr.2006.08.024
   PubMed Web of Science ®Google Scholar
• Crescenzi M. Levels matter: miR-206 and cyclin D1. Cell Cycle 2013; 12(24):3715; PMID:24189536; http://dx.doi.org/10.4161/cc.26962
   PubMed Web of Science ®Google Scholar
• Alteri A, De Vito F, Messina G, Pompili M, Calconi A, Visca P, Mottolese M, Presutti C, Grossi M. Cyclin D1 is a major target of miR-206 in cell differentiation and transformation. Cell Cycle 2013; 12(24):3781-90; PMID:24107628; http://dx.doi.org/10.4161/cc.26674
   PubMed Web of Science ®Google Scholar
• Farhang Ghahremani M, Goossens S, Nittner D, Bisteau X, Bartunkova S, Zwolinska A, Hulpiau P, Haigh K, Haenebalcke L, Drogat B, et al. p53 promotes VEGF expression and angiogenesis in the absence of an intact p21-Rb pathway. Cell Death Differ 2013; 20(7):888-97; PMID:23449391; http://dx.doi.org/10.1038/cdd.2013.12
   PubMed Web of Science ®Google Scholar
• Han J, Kim YL, Lee KW, Her NG, Ha TK, Yoon S, Jeong SI, Lee JH, Kang MJ, Lee MG, et al. ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.). Cell Death Differ 2013; 20(8):1055-67; PMID:23645206; http://dx.doi.org/10.1038/cdd.2013.33
   PubMed Web of Science ®Google Scholar
• Engel BE, Welsh E, Emmons MF, Santiago-Cardona PG, Cress WD. Expression of integrin alpha 10 is transcriptionally activated by pRb in mouse osteoblasts and is downregulated in multiple solid tumors. Cell Death Dis 2013; 4:e938; PMID:24287699; http://dx.doi.org/10.1038/cddis.2013.461
   PubMed Web of Science ®Google Scholar
• Biasoli D, Kahn SA, Cornélio TA, Furtado M, Campanati L, Chneiweiss H, Moura-Neto V, Borges HL. Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide. Cell Death Dis 2013; 4:e767; PMID:23949216; http://dx.doi.org/10.1038/cddis.2013.283
   PubMed Web of Science ®Google Scholar
• Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle 2013; 12(6):935-43; PMID:23421998; http://dx.doi.org/10.4161/cc.23883
   PubMed Web of Science ®Google Scholar
• Lo HW. Akt destabilizes p57 (Kip2) : Akt at the converging crossroad? Cell Cycle 2013;12(6):870-1; PMID:23470457; http://dx.doi.org/10.4161/cc.24155
   PubMed Web of Science ®Google Scholar
• Guo K, Wang J, Andrés V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995; 15(7):3823-9; PMID:7791789
   PubMed Web of Science ®Google Scholar
• Halevy O1, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267(5200):1018-21; PMID:7863327; http://dx.doi.org/10.1126/science.7863327
   PubMed Web of Science ®Google Scholar
• Maione R, Amati P. Interdependence between muscle differentiation and cell-cycle control. Biochim Biophys Acta 1997 Feb 22; 1332(1):M19-30
   PubMed Web of Science ®Google Scholar
• Zhang P1, Wong C, Liu D, Finegold M, Harper JW, Elledge SJ. p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step. Genes Dev 1999; 13(2):213-24; PMID:9925645; http://dx.doi.org/10.1101/gad.13.2.213
   PubMed Web of Science ®Google Scholar
• Andrés V, Walsh K. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 1996; 132(4):657-66; http://dx.doi.org/10.1083/jcb.132.4.657
   PubMed Web of Science ®Google Scholar
• Walsh K, Perlman H. Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 1997; 7(5):597-602; PMID:9388774; http://dx.doi.org/10.1016/S0959-437X(97)80005-6
   PubMed Web of Science ®Google Scholar
• Marchesi I, Giordano A, Bagella L. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis. Cell Cycle 2014; 13(4):516-27; PMID:24496329; http://dx.doi.org/10.4161/cc.27921
   PubMed Web of Science ®Google Scholar
• Rodhe J, Kavanagh E, Joseph B. TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics. Oncotarget 2013; 4(2):289-97; PMID:23470527
   PubMed Web of Science ®Google Scholar
• Candi E, Agostini M, Melino G, Bernassola F. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors. Hum Mutat 2014a; 35(6):702-14; http://dx.doi.org/10.1002/humu.22523
   PubMed Web of Science ®Google Scholar
• Candi E, Amelio I, Agostini M, Melino G. MicroRNAs and p63 in epithelial stemness. Cell Death Differ 2015; 22(1):12-21; http://dx.doi.org/10.1038/cdd.2014.113
   PubMed Web of Science ®Google Scholar
• Yang, A, Kaghad, M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 1998; 2:305-316; PMID:9774969; http://dx.doi.org/10.1016/S1097-2765(00)80275-0
   PubMed Web of Science ®Google Scholar
• Murray-Zmijewski F, Lane DP, Bourdon JC. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 2006; 13:962-72; PMID:16601753; http://dx.doi.org/10.1038/sj.cdd.4401914
   PubMed Web of Science ®Google Scholar
• Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, Paradisi A, De Laurenzi V, Spagnoli LG, Catani MV, Ramadan S, et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 2006; 13(6):1037-47; PMID:16601749; http://dx.doi.org/10.1038/sj.cdd.4401926
   PubMed Web of Science ®Google Scholar
• Vanbokhoven H, Melino G, Candi E, Declercq W. p63, a story of mice and men. J Invest Dermatol 2011; 131(6):1196-207; PMID:21471985; http://dx.doi.org/10.1038/jid.2011.84
   PubMed Web of Science ®Google Scholar
• Candi E, Dinsdale D, Rufini A, Salomoni P, Knight RA, Mueller M, Krammer PH, Melino G. TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle. 2007;6(3):274-85; PMID:17264681; http://dx.doi.org/10.4161/cc.6.3.3797
   PubMed Web of Science ®Google Scholar
• Crum CP, McKeon F. p63 in epithelial survival, germ cell surveillance, and neoplasia. Annu Rev Pathol 2010; 5:349-71; PMID:20078223; http://dx.doi.org/10.1146/annurev-pathol-121808-102117
   PubMed Web of Science ®Google Scholar
• Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, Rivlin N, Goldfinger N, Folgiero V, Falcioni R, et al. p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity. Cell Death Differ 2013; 20(5):774-83; PMID:23412343; http://dx.doi.org/10.1038/cdd.2013.9
   PubMed Web of Science ®Google Scholar
• Ozaki T, Wu D, Sugimoto H, Nagase H, Nakagawara A. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage. Cell Death Dis. 2013;4:e610; PMID:23618908; http://dx.doi.org/10.1038/cddis.2013.127
   PubMed Web of Science ®Google Scholar
• Hadjal Y, Hadadeh O, Yazidi CE, Barruet E, Binétruy B. A p38MAPK-p53 cascade regulates mesodermal differentiation and neurogenesis of embryonic stem cells. Cell Death Dis 2013; 4:e737; PMID:23887628; http://dx.doi.org/10.1038/cddis.2013.246
   PubMed Web of Science ®Google Scholar
• Gonzalez-Cano L, Hillje AL, Fuertes-Alvarez S, Marques MM, Blanch A, Ian RW, Irwin MS, Schwamborn JC, Marín MC. Regulatory feedback loop between TP73 and TRIM32. Cell Death Dis 2013; 4:e704; PMID:23828567; http://dx.doi.org/10.1038/cddis.2013.224
   PubMed Web of Science ®Google Scholar
• Pitman RT, Wojdyla L, Puri N. Mechanism of DNA damage responses induced by exposure to an oligonucleotide homologous to the telomere overhang in melanoma. Oncotarget 2013; 4(5):761-71; PMID:23800953
   PubMed Web of Science ®Google Scholar
• Ianzano ML, Croci S, Nicoletti G, Palladini A, Landuzzi L, Grosso V, Ranieri D, Dall'Ora M, Santeramo I, Urbini M, et al. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. Oncotarget 2014 Jan 15; 5(1):108-19.
   PubMed Web of Science ®Google Scholar
• Italiano D, Lena AM, Melino G, Candi E. Identification of NCF2/p67phox as a novel p53 target gene. Cell Cycle 2012; 11(24):4589-96; PMID:23187810; http://dx.doi.org/10.4161/cc.22853
   PubMed Web of Science ®Google Scholar
• Mattiske S, Ho K, Noll JE, Neilsen PM, Callen DF, Suetani RJ. TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth. Oncotarget 2013; 4(11):1894-903; PMID:24177167
   PubMed Web of Science ®Google Scholar
• Yaffe D, Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270(5639):725-7; PMID:563524; http://dx.doi.org/10.1038/270725a0
   PubMed Web of Science ®Google Scholar
• Nekulova M, Holcakova J, Nenutil R, Stratmann R, Bouchalova P, Müller P, Mouková L, Coates P J, Borivoj V. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry. Virchows Arch 2013; 1459-4.
   Web of Science ®Google Scholar